“Sympathetic Overactivity and Sleep Deprivation: A Dual Burden in the Development of Metabolic Syndrome in Urban Asian Indian population”
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2025
Project Lead
Dr.Ashwini priyanka V
Authors
Ashwini Priyanka V 1, Aman Naik2 , Sonali Appaiah3 .
Project Status
ongoing
Project Type
Original